NCT02242305View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort

PHASE3CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

November 1, 2008

Primary Completion Date

July 20, 2009

Study Completion Date

July 20, 2009

Conditions
Abdominal Pain
Interventions
DRUG

Hyoscine Butylbromide - Tablet

DRUG

Hyoscine Butylbromide - Capsule

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02242305 - Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort | Biotech Hunter | Biotech Hunter